Effect of Attending Practice Style on Generic Medication Prescribing by Residents in the Clinic Setting: An Observational Study

Journal of General Internal Medicine

Volumn 30, Issue 9, 2015, Pages 1286-1293

  Ryskina, Kira L ^a,b   Dine, C Jessica ^b   Kim, Esther J ^a   Bishop, Tara F ^c   Epstein, Andrew J ^a,b,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Drugs; Graduate; Health care costs; Medical culture; Medical education; Practice variation

Indexed keywords

ATORVASTATIN; GENERIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRESCRIPTION DRUG;

AGED; ARTICLE; ATTENDING PHYSICIAN; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PHYSICIAN; POSTGRADUATE EDUCATION; PRESCRIPTION; RESIDENCY EDUCATION; RESIDENT; RETROSPECTIVE STUDY; UNITED STATES; UNIVERSITY HOSPITAL; ADULT; EDUCATION; INTERNAL MEDICINE; MEDICAL EDUCATION; MEDICAL STAFF; OUTPATIENT DEPARTMENT; STATISTICS AND NUMERICAL DATA;

ADULT; AMBULATORY CARE FACILITIES; DRUGS, GENERIC; EDUCATION, MEDICAL, GRADUATE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERNAL MEDICINE; INTERNSHIP AND RESIDENCY; MALE; MEDICAL STAFF, HOSPITAL; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84939244249     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3323-5     Document Type: Article

References (20)

1. Kuehn BM. Economist: it’s time for tough choices on US health costs. JAMA. 2014;311(24):2469–70.
2. Cooke M. Cost consciousness in patient care – what is medical education’s responsibility? N Engl J Med. 2010;362(14):1253–5.
3. Weinberger SE. Providing high-value, cost conscious care: a critical seventh general competency for physicians. Ann Intern Med. 2011;155:386–8.
4. Korenstein D, Kale M, Levinson W. Teaching value in academic environments: shifting the ivory tower. JAMA. 2013;310(16):1671–2.
5. Detsky AS, Verma AA. A new model for medical education: celebrating restraint. JAMA. 2012;308(13):1329–30.
6. Caverzagie KJ, Iobst WF, Aagaard EM, et al. The internal medicine reporting milestones and the next accreditation system. Ann Intern Med. 2013;158(7):557–9.
7. Hackbarth G, Boccuti C. Transforming graduate medical education to improve health care value. N Engl J Med. 2011;364:693–5.
8. IOM (Institute of Medicine). Graduate medication education that meets the nation’s health needs. Washington, DC: The National Academies Press; 2014.
9. Wilensky GR, Berwick DM. Reforming the financing and governance of GME. N Engl J Med. 2014. doi:10.1056/NEJMp1406174.
10. Hayward RA, Manning WG, McMahon LF, Bernard AM. Do attending or resident physician practice styles account for variations in hospital resource use? Med Care. 1994;32:788–94.
11. Iwashyna TJ, Fuld A, Asch DA, Bellini LM. The impact of residents, interns, and attendings on inpatient laboratory ordering patterns: a report from one university’s hospitalist service. Acad Med. 2011;86:139–45.
12. Ryskina KL, Pesko M, Gossey JT, Caesar EP, Bishop TF. Brand name statin prescribing in a resident ambulatory practice: implications for teaching cost-conscious medicine. Journal of Graduate Medical Education. 2014;6(3):484–8.
13. Mehrotra A, Reid RO, Adams JL, Friedberg MW, McGlynn EA, Hussey PS. Physicians with the least experience have higher cost profiles than do physicians with the most experience. Health Affairs. 2012;31(11):2453–63.
14. Good Stewardship Working Group. The “top 5” lists in primary care: meeting the responsibility of professionalism. Arch Intern Med. 2011;171(15):1385–90.
15. Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 1998;81(5):582–7.
16. Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I. Study Group. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Diabetes Obes Metab. 2005;7(4):430–8.
17. Donohue JM, Morden NE, Gellad WF, Bynum JP, Zhou W, Hanlon JT, Skinner J. Sources of regional variation in Medicare Part D drug spending. N Engl J Med. 2012;366:530–8.
18. Kale MS, Bishop TF, Federman AD, Keyhani S. “Top 5” lists top $5 billion. Arch Intern Med. 2011;171(20):1856–8.
19. Davis DA, Mazmanian PE, Fordis M, Van Harrison R, Thorpe KE, Perrier L. Accuracy of physician self-assessment compared with observed measures of competence: a systematic review. JAMA. 2006;296(9):1094–102.
20. Patel MS, Day S, Small DS, Howell JT, Lautenbach GL, Nierman EH, Volpp KG. Using default options within the electronic health record to increase the prescribing of generic-equivalent medications: a quasi-experimental study. Ann Intern Med. 2014;161(10S):S44–52.